SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001835567-22-000049
Filing Date
2022-06-15
Accepted
2022-06-15 08:04:05
Documents
17
Period of Report
2022-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pear-20220614.htm   iXBRL 8-K 72736
2 EX-10.1 SEVERANCE AND CHANGE IN CONTROL PLAN exhibit101peartherapeutics.htm EX-10.1 132813
3 EX-99.1 PEAR PRESS RELEASE NEW BOARD MEMBERS_06.15.22 ex991pearpressrelease_newb.htm EX-99.1 16855
8 logo-pearxtherapeuticsxfin.jpg GRAPHIC 650556
9 pear-20220614_g1.jpg GRAPHIC 650556
  Complete submission text file 0001835567-22-000049.txt   2858487

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pear-20220614.xsd EX-101.SCH 2328
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pear-20220614_def.xml EX-101.DEF 16648
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pear-20220614_lab.xml EX-101.LAB 32072
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pear-20220614_pre.xml EX-101.PRE 17399
11 EXTRACTED XBRL INSTANCE DOCUMENT pear-20220614_htm.xml XML 15235
Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Filer) CIK: 0001835567 (see all company filings)

IRS No.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39969 | Film No.: 221016650
SIC: 8000 Services-Health Services